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Background/Purpose: In pediatric rheumatology,
the small size of many academic programs translates
into limited mentoring options for early career physi-
cians. To address this “mentorship gap,” in 2011 the
American College of Rheumatology (ACR) and the
Childhood Arthritis and Rheumatology Research Alli-
ance (CARRA) joined together to develop AMIGO, the
ACR/CARRA Mentoring Interest Group, that now
includes greater than half of pediatric rheumatology
fellows and junior faculty in the US and Canada. We
report ongoing program evaluation encompassing pilot
(2011) and full roll-out (2012, 2013) phases of the
AMIGO project.
Methods: Mentees and mentors participating in
the AMIGO project were surveyed via online question-
naire to determine dynamics of contact and perceived
benefit. The entire pediatric rheumatology community
was surveyed in 2011 to determine the state of mentor-
ing and career development, with a repeat survey
planned for early 2014. We tabulated the active dyads as
of January 2014.
Results: As recently reported, detailed evaluation
of the pilot phase 17 months after initial roll-out found
that 19 of 20 pilot AMIGO dyads were still functioning,
with substantial benefit noted by mentees in career
guidance, scholarship, and job satisfaction. Benefits re-
ported by mentors included improvement of their men-
toring skills and development of their academic portfo-
lios. Both mentees and mentors reported improved
connectedness to the wider pediatric rheumatology com-
munity. 83 additional dyads were matched prior to 2012
and 2013 ACR meetings. Comparison of these 17-month
pilot results to a December 2013/January 2014 survey of
all active AMIGO participants is ongoing. A question-
naire administered to the whole pediatric rheumatology
community in 2011 (n  135 respondents, including an
estimated 64–70% response rate among fellows and
junior faculty) found that approximately 60% of fellows
and junior faculty had a career development mentor. We
will assess whether the AMIGO program has had a
global impact upon the mentoring culture in pediatric
rheumatology by collecting community-wide survey data
in 2014 and then comparing to 2011 data.
Conclusion: The 2011 AMIGO pilot program has
confirmed the feasibility of a North American inter-
institutional mentoring program in pediatric rheuma-
tology. Participants identified benefits to both mentees
and mentors in multiple domains, most prominently in
career guidance, a core goal of the program. Ongoing
program evaluation will determine how much of this
benefit has been sustained after participation was
opened to the whole community, and whether the
program has had a measureable impact on the overall
state of mentoring in pediatric rheumatology.
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